Establishment Labs Holdings Operating Margin 2017-2025 | ESTA
Current and historical operating margin for Establishment Labs Holdings (ESTA) over the last 10 years. The current operating profit margin for Establishment Labs Holdings as of March 31, 2025 is -48.81%.
| Establishment Labs Holdings Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.17B | $-0.06B | -34.12% |
| 2024-12-31 | $0.17B | $-0.05B | -30.12% |
| 2024-09-30 | $0.15B | $-0.05B | -34.64% |
| 2024-06-30 | $0.15B | $-0.06B | -40.13% |
| 2024-03-31 | $0.16B | $-0.07B | -42.04% |
| 2023-12-31 | $0.17B | $-0.07B | -38.92% |
| 2023-09-30 | $0.18B | $-0.06B | -31.28% |
| 2023-06-30 | $0.18B | $-0.05B | -25.84% |
| 2023-03-31 | $0.17B | $-0.04B | -24.71% |
| 2022-12-31 | $0.16B | $-0.04B | -24.84% |
| 2022-09-30 | $0.15B | $-0.04B | -23.68% |
| 2022-06-30 | $0.14B | $-0.03B | -23.78% |
| 2022-03-31 | $0.13B | $-0.03B | -21.64% |
| 2021-12-31 | $0.13B | $-0.03B | -19.84% |
| 2021-09-30 | $0.12B | $-0.02B | -20.34% |
| 2021-06-30 | $0.11B | $-0.02B | -16.07% |
| 2021-03-31 | $0.09B | $-0.02B | -25.56% |
| 2020-12-31 | $0.08B | $-0.03B | -34.52% |
| 2020-09-30 | $0.08B | $-0.03B | -30.86% |
| 2020-06-30 | $0.08B | $-0.03B | -38.27% |
| 2020-03-31 | $0.09B | $-0.03B | -32.26% |
| 2019-12-31 | $0.09B | $-0.03B | -33.33% |
| 2019-09-30 | $0.08B | $-0.04B | -42.68% |
| 2019-06-30 | $0.08B | $-0.03B | -42.67% |
| 2019-03-31 | $0.07B | $-0.03B | -43.28% |
| 2018-12-31 | $0.06B | $-0.02B | -39.34% |
| 2018-09-30 | $0.06B | $-0.02B | -35.09% |
| 2018-06-30 | $0.05B | $-0.02B | -41.67% |
| 2018-03-31 | $0.04B | $-0.02B | -44.19% |
| 2017-12-31 | $0.04B | $-0.02B | -57.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.089B | $0.166B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.538B | 26.55 |
| Elevance Health (ELV) | United States | $93.196B | 12.03 |
| CVS Health (CVS) | United States | $80.632B | 10.02 |
| Cencora (COR) | United States | $56.777B | 19.75 |
| DiDi Global (DIDIY) | China | $22.309B | 33.86 |
| Natera (NTRA) | United States | $21.101B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.924B | 13.68 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.447B | 0.00 |
| CochLear (CHEOY) | Australia | $11.597B | 0.00 |
| Revvity (RVTY) | United States | $11.030B | 18.98 |
| ICON (ICLR) | Ireland | $10.666B | 9.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Doximity (DOCS) | United States | $9.895B | 46.09 |
| Avantor (AVTR) | United States | $9.179B | 13.34 |
| Medpace Holdings (MEDP) | United States | $8.813B | 23.41 |
| HealthEquity (HQY) | United States | $8.752B | 43.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.050B | 13.81 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.153B | 24.48 |
| BrightSpring Health Services (BTSG) | United States | $4.151B | 38.42 |
| Sotera Health (SHC) | United States | $3.639B | 20.68 |
| Alignment Healthcare (ALHC) | United States | $3.102B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.973B | 38.67 |
| Concentras Parent (CON) | United States | $2.889B | 16.70 |
| Organon (OGN) | United States | $2.277B | 2.42 |
| Ardent Health Partners (ARDT) | United States | $2.164B | 9.23 |
| GeneDx Holdings (WGS) | United States | $2.058B | 79.24 |
| Premier (PINC) | United States | $1.902B | 14.44 |
| Progyny (PGNY) | United States | $1.875B | 41.26 |
| PACS (PACS) | United States | $1.606B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.418B | 28.36 |
| Pediatrix Medical (MD) | United States | $1.302B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.288B | 0.00 |
| Agilon Health (AGL) | United States | $1.027B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.988B | 15.43 |
| Nutex Health (NUTX) | United States | $0.986B | 14.90 |
| AMN Healthcare Services Inc (AMN) | United States | $0.878B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.718B | 4.84 |
| InnovAge Holding (INNV) | United States | $0.572B | 0.00 |
| Enhabit (EHAB) | United States | $0.537B | 44.21 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 11.67 |
| LifeMD (LFMD) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| SBC Medicals (SBC) | United States | $0.368B | 0.00 |
| Beauty Health (SKIN) | United States | $0.212B | 0.00 |
| Oncology Institute (TOI) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| KindlyMD (KDLY) | United States | $0.092B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |